Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Schinke

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Der Nervenarzt|April 3, 2010
[Forensic psychiatry and behavioural analysis]J Nitschke, D Schinke, B Ottermann, et al.
Journal of Computer Assisted Tomography|September 1, 1995
CT cisternography in congenital perilymphatic fistula of the inner earK O Lövblad, C Ozdoba, S Negri, et al.
Expert Review of Cardiovascular Therapy|November 23, 2017
Cardiovascular complications of multiple myeloma in the elderlyPankaj Mathur, Sharmilan Thanendrarajan, Hakan Paydak, et al.
Blood Cancer Journal|January 6, 2026
Peripheral blood immune cell profiling and response to BCMA CAR-T cell therapy in relapsed refractory multiple myelomaToshali Pandey, Bhavesh Mohan Lal, Jawad Alrawabdeh, et al.
Blood Cancer Journal|March 31, 2026
Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patientsHira Cheema, Asis Shrestha, Syed Naqvi, et al.
European Journal of Haematology|October 27, 2020
Monitoring treatment response and disease progression in myeloma with circulating cell-free DNAShayu Deshpande, Ruslana G Tytarenko, Yan Wang, et al.
Blood Cancer Journal|August 11, 2019
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q SyndromeJeffrey R Sawyer, Erming Tian, Brian A Walker, et al.
JAMA Oncology|June 5, 2025
Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols: A Secondary Analysis of 3 Clinical TrialsSamer Al Hadidi, Obada Ehab Ababneh, Carolina D Schinke, et al.
Blood Advances|December 5, 2023
Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-upSamer Al Hadidi, Obada Ehab Ababneh, Carolina D Schinke, et al.
Haematologica|March 24, 2018
Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myelomaFaith E Davies, Adam Rosenthal, Leo Rasche, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Der Nervenarzt|April 3, 2010
[Forensic psychiatry and behavioural analysis]J Nitschke, D Schinke, B Ottermann, et al.
Journal of Computer Assisted Tomography|September 1, 1995
CT cisternography in congenital perilymphatic fistula of the inner earK O Lövblad, C Ozdoba, S Negri, et al.
Expert Review of Cardiovascular Therapy|November 23, 2017
Cardiovascular complications of multiple myeloma in the elderlyPankaj Mathur, Sharmilan Thanendrarajan, Hakan Paydak, et al.
Blood Cancer Journal|January 6, 2026
Peripheral blood immune cell profiling and response to BCMA CAR-T cell therapy in relapsed refractory multiple myelomaToshali Pandey, Bhavesh Mohan Lal, Jawad Alrawabdeh, et al.
Blood Cancer Journal|March 31, 2026
Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patientsHira Cheema, Asis Shrestha, Syed Naqvi, et al.
European Journal of Haematology|October 27, 2020
Monitoring treatment response and disease progression in myeloma with circulating cell-free DNAShayu Deshpande, Ruslana G Tytarenko, Yan Wang, et al.
Blood Cancer Journal|August 11, 2019
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q SyndromeJeffrey R Sawyer, Erming Tian, Brian A Walker, et al.
JAMA Oncology|June 5, 2025
Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols: A Secondary Analysis of 3 Clinical TrialsSamer Al Hadidi, Obada Ehab Ababneh, Carolina D Schinke, et al.
Blood Advances|December 5, 2023
Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-upSamer Al Hadidi, Obada Ehab Ababneh, Carolina D Schinke, et al.
Haematologica|March 24, 2018
Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myelomaFaith E Davies, Adam Rosenthal, Leo Rasche, et al.
Pageof 2